詳細検索

詳細検索

×

キーワード検索の使い方

×
A
B
C
D
E
F
G
H
I
J
L
M
O
P
Q
R
S
T
U
V
W
X
日

お問い合わせ

Global Blood Purification Therapy Market Outlook, InDepth Analysis & Forecast to 2032

Global Blood Purification Therapy Market Outlook, InDepth Analysis & Forecast to 2032


The global Blood Purification Therapy market is projected to grow from US$ 21600 million in 2025 to US$ 31617 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and... もっと見る

　

　

出版社
QYResearch
QYリサーチ
出版年月
2026年10月22日
電子版価格
US$4,900
シングルユーザライセンス
ライセンス・価格情報／注文方法はこちら
納期
5-7営業日
言語
英語

英語原文をAIを使って翻訳しています。


　

お問い合わせ

お問合せ種類／内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る



図表リスト

List of Tables
Table 1. Global Blood Purification Therapy Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Blood Purification Therapy Market Size Growth Rate by Product Form, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Blood Purification Therapy Market Size Growth Rate by Care Setting, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Blood Purification Therapy Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Blood Purification Therapy Revenue by Region (US$ Million), 2021-2026
Table 7. Global Blood Purification Therapy Revenue by Region (US$ Million), 2027-2032
Table 8. Global Blood Purification Therapy Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Blood Purification Therapy Sales by Region (K Units), 2021-2026
Table 10. Global Blood Purification Therapy Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Blood Purification Therapy Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Blood Purification Therapy Sales Share by Manufacturers (2021-2026)
Table 14. Global Blood Purification Therapy Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Blood Purification Therapy Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Blood Purification Therapy Revenue, 2025
Table 18. Global Blood Purification Therapy Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Blood Purification Therapy Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Blood Purification Therapy Manufacturing Base and Headquarters
Table 21. Global Blood Purification Therapy Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Blood Purification Therapy Sales Volume by Type (K Units), 2021-2026
Table 25. Global Blood Purification Therapy Sales Volume by Type (K Units), 2027-2032
Table 26. Global Blood Purification Therapy Revenue by Type (US$ Million), 2021-2026
Table 27. Global Blood Purification Therapy Revenue by Type (US$ Million), 2027-2032
Table 28. Global Blood Purification Therapy Sales Volume by Product Form (K Units), 2021-2026
Table 29. Global Blood Purification Therapy Sales Volume by Product Form (K Units), 2027-2032
Table 30. Global Blood Purification Therapy Revenue by Product Form (US$ Million), 2021-2026
Table 31. Global Blood Purification Therapy Revenue by Product Form (US$ Million), 2027-2032
Table 32. Global Blood Purification Therapy Sales Volume by Care Setting (K Units), 2021-2026
Table 33. Global Blood Purification Therapy Sales Volume by Care Setting (K Units), 2027-2032
Table 34. Global Blood Purification Therapy Revenue by Care Setting (US$ Million), 2021-2026
Table 35. Global Blood Purification Therapy Revenue by Care Setting (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Blood Purification Therapy Sales by Application (K Units), 2021-2026
Table 38. Global Blood Purification Therapy Sales by Application (K Units), 2027-2032
Table 39. Blood Purification Therapy High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Blood Purification Therapy Revenue by Application (US$ Million), 2021-2026
Table 41. Global Blood Purification Therapy Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Blood Purification Therapy Growth Accelerators and Market Barriers
Table 45. North America Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Blood Purification Therapy Growth Accelerators and Market Barriers
Table 48. Europe Blood Purification Therapy Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Blood Purification Therapy Growth Accelerators and Market Barriers
Table 53. Southeast Asia Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Blood Purification Therapy Investment Opportunities and Key Challenges
Table 55. Central and South America Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Blood Purification Therapy Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Chongqing Shanwaishan Corporation Information
Table 59. Chongqing Shanwaishan Description and Major Businesses
Table 60. Chongqing Shanwaishan Product Models, Descriptions and Specifications
Table 61. Chongqing Shanwaishan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Chongqing Shanwaishan Sales Value Proportion by Product in 2025
Table 63. Chongqing Shanwaishan Sales Value Proportion by Application in 2025
Table 64. Chongqing Shanwaishan Sales Value Proportion by Geographic Area in 2025
Table 65. Chongqing Shanwaishan Blood Purification Therapy SWOT Analysis
Table 66. Chongqing Shanwaishan Recent Developments
Table 67. Weigao Corporation Information
Table 68. Weigao Description and Major Businesses
Table 69. Weigao Product Models, Descriptions and Specifications
Table 70. Weigao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Weigao Sales Value Proportion by Product in 2025
Table 72. Weigao Sales Value Proportion by Application in 2025
Table 73. Weigao Sales Value Proportion by Geographic Area in 2025
Table 74. Weigao Blood Purification Therapy SWOT Analysis
Table 75. Weigao Recent Developments
Table 76. Sanxin Medtec Corporation Information
Table 77. Sanxin Medtec Description and Major Businesses
Table 78. Sanxin Medtec Product Models, Descriptions and Specifications
Table 79. Sanxin Medtec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanxin Medtec Sales Value Proportion by Product in 2025
Table 81. Sanxin Medtec Sales Value Proportion by Application in 2025
Table 82. Sanxin Medtec Sales Value Proportion by Geographic Area in 2025
Table 83. Sanxin Medtec Blood Purification Therapy SWOT Analysis
Table 84. Sanxin Medtec Recent Developments
Table 85. Biolight Corporation Information
Table 86. Biolight Description and Major Businesses
Table 87. Biolight Product Models, Descriptions and Specifications
Table 88. Biolight Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Biolight Sales Value Proportion by Product in 2025
Table 90. Biolight Sales Value Proportion by Application in 2025
Table 91. Biolight Sales Value Proportion by Geographic Area in 2025
Table 92. Biolight Blood Purification Therapy SWOT Analysis
Table 93. Biolight Recent Developments
Table 94. Bain Medical Corporation Information
Table 95. Bain Medical Description and Major Businesses
Table 96. Bain Medical Product Models, Descriptions and Specifications
Table 97. Bain Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Bain Medical Sales Value Proportion by Product in 2025
Table 99. Bain Medical Sales Value Proportion by Application in 2025
Table 100. Bain Medical Sales Value Proportion by Geographic Area in 2025
Table 101. Bain Medical Blood Purification Therapy SWOT Analysis
Table 102. Bain Medical Recent Developments
Table 103. Jafron Biomedical Corporation Information
Table 104. Jafron Biomedical Description and Major Businesses
Table 105. Jafron Biomedical Product Models, Descriptions and Specifications
Table 106. Jafron Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Jafron Biomedical Recent Developments
Table 108. Peony Medical Corporation Information
Table 109. Peony Medical Description and Major Businesses
Table 110. Peony Medical Product Models, Descriptions and Specifications
Table 111. Peony Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Peony Medical Recent Developments
Table 113. Guangzhou OCI Medical Corporation Information
Table 114. Guangzhou OCI Medical Description and Major Businesses
Table 115. Guangzhou OCI Medical Product Models, Descriptions and Specifications
Table 116. Guangzhou OCI Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Guangzhou OCI Medical Recent Developments
Table 118. Koncen Biotech Corporation Information
Table 119. Koncen Biotech Description and Major Businesses
Table 120. Koncen Biotech Product Models, Descriptions and Specifications
Table 121. Koncen Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Koncen Biotech Recent Developments
Table 123. Ningbo Tianyi Medical Corporation Information
Table 124. Ningbo Tianyi Medical Description and Major Businesses
Table 125. Ningbo Tianyi Medical Product Models, Descriptions and Specifications
Table 126. Ningbo Tianyi Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Ningbo Tianyi Medical Recent Developments
Table 128. Wellead Medical Corporation Information
Table 129. Wellead Medical Description and Major Businesses
Table 130. Wellead Medical Product Models, Descriptions and Specifications
Table 131. Wellead Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Wellead Medical Recent Developments
Table 133. Shinva Corporation Information
Table 134. Shinva Description and Major Businesses
Table 135. Shinva Product Models, Descriptions and Specifications
Table 136. Shinva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shinva Recent Developments
Table 138. Chengdu Wesley Corporation Information
Table 139. Chengdu Wesley Description and Major Businesses
Table 140. Chengdu Wesley Product Models, Descriptions and Specifications
Table 141. Chengdu Wesley Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Chengdu Wesley Recent Developments
Table 143. Tuoren Medical Corporation Information
Table 144. Tuoren Medical Description and Major Businesses
Table 145. Tuoren Medical Product Models, Descriptions and Specifications
Table 146. Tuoren Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Tuoren Medical Recent Developments
Table 148. Jiangxi Hongda Corporation Information
Table 149. Jiangxi Hongda Description and Major Businesses
Table 150. Jiangxi Hongda Product Models, Descriptions and Specifications
Table 151. Jiangxi Hongda Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Jiangxi Hongda Recent Developments
Table 153. Guanhuai Medical Corporation Information
Table 154. Guanhuai Medical Description and Major Businesses
Table 155. Guanhuai Medical Product Models, Descriptions and Specifications
Table 156. Guanhuai Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Guanhuai Medical Recent Developments
Table 158. Guangzhou Jihua Corporation Information
Table 159. Guangzhou Jihua Description and Major Businesses
Table 160. Guangzhou Jihua Product Models, Descriptions and Specifications
Table 161. Guangzhou Jihua Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Guangzhou Jihua Recent Developments
Table 163. Kangbei Medical Corporation Information
Table 164. Kangbei Medical Description and Major Businesses
Table 165. Kangbei Medical Product Models, Descriptions and Specifications
Table 166. Kangbei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Kangbei Medical Recent Developments
Table 168. Foshan Biosun Medical Corporation Information
Table 169. Foshan Biosun Medical Description and Major Businesses
Table 170. Foshan Biosun Medical Product Models, Descriptions and Specifications
Table 171. Foshan Biosun Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Foshan Biosun Medical Recent Developments
Table 173. Fresenius Medical Care Corporation Information
Table 174. Fresenius Medical Care Description and Major Businesses
Table 175. Fresenius Medical Care Product Models, Descriptions and Specifications
Table 176. Fresenius Medical Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Fresenius Medical Care Recent Developments
Table 178. Nikkiso Corporation Information
Table 179. Nikkiso Description and Major Businesses
Table 180. Nikkiso Product Models, Descriptions and Specifications
Table 181. Nikkiso Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Nikkiso Recent Developments
Table 183. B. Braun Corporation Information
Table 184. B. Braun Description and Major Businesses
Table 185. B. Braun Product Models, Descriptions and Specifications
Table 186. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. B. Braun Recent Developments
Table 188. Vantive Corporation Information
Table 189. Vantive Description and Major Businesses
Table 190. Vantive Product Models, Descriptions and Specifications
Table 191. Vantive Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Vantive Recent Developments
Table 193. Asahi Kasei Medical Corporation Information
Table 194. Asahi Kasei Medical Description and Major Businesses
Table 195. Asahi Kasei Medical Product Models, Descriptions and Specifications
Table 196. Asahi Kasei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Asahi Kasei Medical Recent Developments
Table 198. Nipro Corporation Information
Table 199. Nipro Description and Major Businesses
Table 200. Nipro Product Models, Descriptions and Specifications
Table 201. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Nipro Recent Developments
Table 203. Toray Medical Corporation Information
Table 204. Toray Medical Description and Major Businesses
Table 205. Toray Medical Product Models, Descriptions and Specifications
Table 206. Toray Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Toray Medical Recent Developments
Table 208. Kaneka Medix Corporation Information
Table 209. Kaneka Medix Description and Major Businesses
Table 210. Kaneka Medix Product Models, Descriptions and Specifications
Table 211. Kaneka Medix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Kaneka Medix Recent Developments
Table 213. CytoSorbents Corporation Information
Table 214. CytoSorbents Description and Major Businesses
Table 215. CytoSorbents Product Models, Descriptions and Specifications
Table 216. CytoSorbents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. CytoSorbents Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources

List of Figures
Figure 1. Blood Purification Therapy Product Picture
Figure 2. Global Blood Purification Therapy Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Hemodialysis Product Picture
Figure 4. Hemoperfusion Product Picture
Figure 5. Hemofiltration Product Picture
Figure 6. Continuous Renal Replacement Therapy Product Picture
Figure 7. Plasma Exchange And Plasma Adsorption Product Picture
Figure 8. Other Product Picture
Figure 9. Global Blood Purification Therapy Market Size Growth Rate by Product Form, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Blood Purification Equipment Product Picture
Figure 11. Blood Purification Consumables Product Picture
Figure 12. Global Blood Purification Therapy Market Size Growth Rate by Care Setting, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Hospitals Product Picture
Figure 14. Blood Purification Centers Product Picture
Figure 15. Home Care Product Picture
Figure 16. Other Product Picture
Figure 17. Global Blood Purification Therapy Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 18. End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
Figure 19. Acute Kidney Injury And Critical Care Blood Purification
Figure 20. Liver Failure And Artificial Liver Support
Figure 21. Poisoning Blood Purification
Figure 22. Immune-Mediated Disease Blood Purification
Figure 23. Metabolic Diseases and Special Component Removal
Figure 24. Other
Figure 25. Blood Purification Therapy Report Years Considered
Figure 26. Global Blood Purification Therapy Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 28. Global Blood Purification Therapy Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 29. Global Blood Purification Therapy Revenue-Based Market Share by Region (2021-2032)
Figure 30. Global Blood Purification Therapy Sales (K Units), 2021-2032
Figure 31. Global Blood Purification Therapy Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 32. Global Blood Purification Therapy Sales Market Share by Region (2021-2032)
Figure 33. Top 5 and Top 10 Manufacturers Blood Purification Therapy Sales Volume Market Share in 2025
Figure 34. Global Blood Purification Therapy Revenue-Based Market Share Ranking (2025)
Figure 35. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 36. Hemodialysis Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Hemoperfusion Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Hemofiltration Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Continuous Renal Replacement Therapy Revenue-Based Market Share by Manufacturer in 2025
Figure 40. Plasma Exchange And Plasma Adsorption Revenue-Based Market Share by Manufacturer in 2025
Figure 41. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 42. Global Blood Purification Therapy Sales Volume-Based Market Share by Type (2021-2032)
Figure 43. Global Blood Purification Therapy Revenue-Based Market Share by Type (2021-2032)
Figure 44. Global Blood Purification Therapy ASP by Type (US$/Unit), 2021-2032
Figure 45. Global Blood Purification Therapy Sales Volume-Based Market Share by Product Form (2021-2032)
Figure 46. Global Blood Purification Therapy Revenue-Based Market Share by Product Form (2021-2032)
Figure 47. Global Blood Purification Therapy ASP by Product Form (US$/Unit), 2021-2032
Figure 48. Global Blood Purification Therapy Sales Volume-Based Market Share by Care Setting (2021-2032)
Figure 49. Global Blood Purification Therapy Revenue-Based Market Share by Care Setting (2021-2032)
Figure 50. Global Blood Purification Therapy ASP by Care Setting (US$/Unit), 2021-2032
Figure 51. Global Blood Purification Therapy Sales Market Share by Application (2021-2032)
Figure 52. Global Blood Purification Therapy Revenue-Based Market Share by Application (2021-2032)
Figure 53. Global Blood Purification Therapy ASP by Application (US$/Unit), 2021-2032
Figure 54. North America Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 55. North America Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 56. North America Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 57. North America Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 58. North America Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. US Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 60. Canada Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 61. Mexico Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 62. Europe Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 63. Europe Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 64. Europe Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 65. Europe Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 66. Europe Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Germany Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 68. France Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 69. U.K. Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 70. Italy Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 71. Russia Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 72. Asia-Pacific Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 73. Asia-Pacific Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 74. Asia-Pacific Top 8 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 75. Asia-Pacific Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 76. Asia-Pacific Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Indonesia Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 78. Japan Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 79. South Korea Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 80. China Taiwan Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 81. India Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 82. Central and South America Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 83. Central and South America Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 84. Central and South America Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 85. Central and South America Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 86. Central and South America Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 87. Brazil Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 88. Argentina Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 89. Middle East, and Africa Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 90. Middle East and Africa Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 91. Middle East and Africa Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 92. Middle East and Africa Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 93. Middle East and Africa Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 94. GCC Countries Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 95. Turkey Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 96. Egypt Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 97. South Africa Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 98. Blood Purification Therapy Industry Chain Mapping
Figure 99. Regional Blood Purification Therapy Manufacturing Base Distribution (%)
Figure 100. Global Blood Purification Therapy Production Market Share by Region (2021-2032)
Figure 101. Blood Purification Therapy Production Process
Figure 102. Regional Blood Purification Therapy Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed

　

ページTOPに戻る


　

Summary

The global Blood Purification Therapy market is projected to grow from US$ 21600 million in 2025 to US$ 31617 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Blood Purification refers to a group of extracorporeal therapies that remove uremic toxins, excess fluid, electrolytes, drugs and poisons, inflammatory mediators, bilirubin, pathogenic antibodies and other harmful blood components through diffusion, convection, adsorption, plasma separation and exchange, or combinations of these mechanisms, thereby replacing or supporting renal, hepatic, immune and metabolic functions. This catalog covers both equipment and core consumables used in hemodialysis, hemoperfusion, hemofiltration, continuous renal replacement therapy (CRRT), plasma exchange/plasma adsorption and other related blood-purification modalities. Equipment includes hemodialysis machines, blood-purification systems, CRRT systems, hemoperfusion machines, plasma-exchange systems and multi-therapy extracorporeal platforms, while core consumables include dialyzers, hemofilters, hemoperfusion cartridges/adsorption columns, plasma separators, CRRT filters and circuits, dialysis bloodlines, replacement fluids and other dialysis-related disposables. On a combined physical-unit basis for major equipment and core single-use consumables, global Blood Purification production reached approximately 1,350,000 K Units in 2025.
Growth in the end-stage kidney disease population remains the most stable source of demand for the global blood-purification market. Population aging and the increasing burden of diabetes and hypertension continue to expand the maintenance dialysis population while supporting broader use of high-flux dialysis, hemodiafiltration, adsorption-combination therapies and more biocompatible membrane technologies. Blood-purification equipment has a relatively long replacement cycle, whereas dialyzers, bloodlines, hemoperfusion cartridges, filters and dialysis concentrates are repeatedly consumed, making treatment frequency, disposable utilization and installed equipment base the core drivers of recurring industry revenue.
Acute kidney injury, sepsis, multiple-organ dysfunction, liver failure, poisoning and severe immune or metabolic disorders are extending blood purification beyond conventional renal replacement toward multi-organ support. The growing use of CRRT, hemoperfusion, plasma exchange, plasma adsorption and artificial-liver support in critical care is increasing requirements for precise fluid balance, stable continuous treatment and efficient removal of inflammatory mediators and protein-bound toxins. Equipment is evolving from single-modality systems toward multi-therapy platforms, while consumables are moving toward high-performance membranes, selective sorbents, lower albumin loss, improved anticoagulation compatibility and better biocompatibility, increasing the value content of the product mix.
China has become an important global manufacturing and demand center for blood-purification equipment and consumables, with domestic supply chains expanding rapidly in dialysis machines, dialyzers, hemoperfusion cartridges, tubing sets, CRRT circuits and adsorption materials. Volume-based procurement and reimbursement optimization improve treatment accessibility but also intensify price competition in mature disposable categories, encouraging manufacturers to differentiate through local membrane production, advanced sorbents, intelligent fluid management, connectivity and integrated equipment-consumables portfolios. At the same time, home dialysis, expansion of regional blood-purification centers, standardized critical-care treatment and international regulatory expansion create additional opportunities for manufacturers with strong production capabilities and quality systems.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Blood Purification Therapy market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Chongqing Shanwaishan
Weigao
Sanxin Medtec
Biolight
Bain Medical
Jafron Biomedical
Peony Medical
Guangzhou OCI Medical
Koncen Biotech
Ningbo Tianyi Medical
Wellead Medical
Shinva
Chengdu Wesley
Tuoren Medical
Jiangxi Hongda
Guanhuai Medical
Guangzhou Jihua
Kangbei Medical
Foshan Biosun Medical
Fresenius Medical Care
Nikkiso
B. Braun
Vantive
Asahi Kasei Medical
Nipro
Toray Medical
Kaneka Medix
CytoSorbents
Segment by Type
Hemodialysis
Hemoperfusion
Hemofiltration
Continuous Renal Replacement Therapy
Plasma Exchange And Plasma Adsorption
Other
Segment by Product Form
Blood Purification Equipment
Blood Purification Consumables
Segment by Care Setting
Hospitals
Blood Purification Centers
Home Care
Other
Segment by Application
End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
Acute Kidney Injury And Critical Care Blood Purification
Liver Failure And Artificial Liver Support
Poisoning Blood Purification
Immune-Mediated Disease Blood Purification
Metabolic Diseases and Special Component Removal
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Blood Purification Therapy study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.


ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Introduction to Blood Purification Therapy: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Blood Purification Therapy Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Hemodialysis
1.2.3 Hemoperfusion
1.2.4 Hemofiltration
1.2.5 Continuous Renal Replacement Therapy
1.2.6 Plasma Exchange And Plasma Adsorption
1.2.7 Other
1.3 Market Segmentation by Product Form
1.3.1 Global Blood Purification Therapy Market Size by Product Form, 2021 vs 2025 vs 2032
1.3.2 Blood Purification Equipment
1.3.3 Blood Purification Consumables
1.4 Market Segmentation by Care Setting
1.4.1 Global Blood Purification Therapy Market Size by Care Setting, 2021 vs 2025 vs 2032
1.4.2 Hospitals
1.4.3 Blood Purification Centers
1.4.4 Home Care
1.4.5 Other
1.5 Market Segmentation by Application
1.5.1 Global Blood Purification Therapy Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
1.5.3 Acute Kidney Injury And Critical Care Blood Purification
1.5.4 Liver Failure And Artificial Liver Support
1.5.5 Poisoning Blood Purification
1.5.6 Immune-Mediated Disease Blood Purification
1.5.7 Metabolic Diseases and Special Component Removal
1.5.8 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Blood Purification Therapy Revenue Estimates and Forecasts (2021-2032)
2.2 Global Blood Purification Therapy Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Blood Purification Therapy Sales Estimates and Forecasts (2021-2032)
2.4 Global Blood Purification Therapy Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Blood Purification Therapy Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Blood Purification Therapy Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Hemodialysis: Market Share by Key Manufacturers
3.5.2 Hemoperfusion: Market Share by Key Manufacturers
3.5.3 Hemofiltration: Market Share by Key Manufacturers
3.5.4 Continuous Renal Replacement Therapy: Market Share by Key Manufacturers
3.5.5 Plasma Exchange And Plasma Adsorption: Market Share by Key Manufacturers
3.5.6 Other: Market Share by Key Manufacturers
3.6 Global Blood Purification Therapy Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Blood Purification Therapy Sales Performance by Type
4.1.1 Global Blood Purification Therapy Sales Volume by Type (2021-2032)
4.1.2 Global Blood Purification Therapy Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Blood Purification Therapy Sales Performance by Product Form
4.2.1 Global Blood Purification Therapy Sales Volume by Product Form (2021-2032)
4.2.2 Global Blood Purification Therapy Revenue by Product Form (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Product Form (2021-2032)
4.3 Global Blood Purification Therapy Sales Performance by Care Setting
4.3.1 Global Blood Purification Therapy Sales Volume by Care Setting (2021-2032)
4.3.2 Global Blood Purification Therapy Revenue by Care Setting (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Care Setting (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Blood Purification Therapy Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Blood Purification Therapy Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Blood Purification Therapy Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Blood Purification Therapy Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Blood Purification Therapy Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Blood Purification Therapy Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Blood Purification Therapy Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Blood Purification Therapy Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Blood Purification Therapy Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Blood Purification Therapy Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Blood Purification Therapy Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Blood Purification Therapy Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Chongqing Shanwaishan
11.1.1 Chongqing Shanwaishan Corporation Information
11.1.2 Chongqing Shanwaishan Business Overview
11.1.3 Chongqing Shanwaishan Blood Purification Therapy Product Models, Descriptions and Specifications
11.1.4 Chongqing Shanwaishan Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Chongqing Shanwaishan Blood Purification Therapy Sales by Product in 2025
11.1.6 Chongqing Shanwaishan Blood Purification Therapy Sales by Application in 2025
11.1.7 Chongqing Shanwaishan Blood Purification Therapy Sales by Geographic Area in 2025
11.1.8 Chongqing Shanwaishan Blood Purification Therapy SWOT Analysis
11.1.9 Chongqing Shanwaishan Recent Developments
11.2 Weigao
11.2.1 Weigao Corporation Information
11.2.2 Weigao Business Overview
11.2.3 Weigao Blood Purification Therapy Product Models, Descriptions and Specifications
11.2.4 Weigao Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Weigao Blood Purification Therapy Sales by Product in 2025
11.2.6 Weigao Blood Purification Therapy Sales by Application in 2025
11.2.7 Weigao Blood Purification Therapy Sales by Geographic Area in 2025
11.2.8 Weigao Blood Purification Therapy SWOT Analysis
11.2.9 Weigao Recent Developments
11.3 Sanxin Medtec
11.3.1 Sanxin Medtec Corporation Information
11.3.2 Sanxin Medtec Business Overview
11.3.3 Sanxin Medtec Blood Purification Therapy Product Models, Descriptions and Specifications
11.3.4 Sanxin Medtec Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Sanxin Medtec Blood Purification Therapy Sales by Product in 2025
11.3.6 Sanxin Medtec Blood Purification Therapy Sales by Application in 2025
11.3.7 Sanxin Medtec Blood Purification Therapy Sales by Geographic Area in 2025
11.3.8 Sanxin Medtec Blood Purification Therapy SWOT Analysis
11.3.9 Sanxin Medtec Recent Developments
11.4 Biolight
11.4.1 Biolight Corporation Information
11.4.2 Biolight Business Overview
11.4.3 Biolight Blood Purification Therapy Product Models, Descriptions and Specifications
11.4.4 Biolight Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Biolight Blood Purification Therapy Sales by Product in 2025
11.4.6 Biolight Blood Purification Therapy Sales by Application in 2025
11.4.7 Biolight Blood Purification Therapy Sales by Geographic Area in 2025
11.4.8 Biolight Blood Purification Therapy SWOT Analysis
11.4.9 Biolight Recent Developments
11.5 Bain Medical
11.5.1 Bain Medical Corporation Information
11.5.2 Bain Medical Business Overview
11.5.3 Bain Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.5.4 Bain Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Bain Medical Blood Purification Therapy Sales by Product in 2025
11.5.6 Bain Medical Blood Purification Therapy Sales by Application in 2025
11.5.7 Bain Medical Blood Purification Therapy Sales by Geographic Area in 2025
11.5.8 Bain Medical Blood Purification Therapy SWOT Analysis
11.5.9 Bain Medical Recent Developments
11.6 Jafron Biomedical
11.6.1 Jafron Biomedical Corporation Information
11.6.2 Jafron Biomedical Business Overview
11.6.3 Jafron Biomedical Blood Purification Therapy Product Models, Descriptions and Specifications
11.6.4 Jafron Biomedical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Jafron Biomedical Recent Developments
11.7 Peony Medical
11.7.1 Peony Medical Corporation Information
11.7.2 Peony Medical Business Overview
11.7.3 Peony Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.7.4 Peony Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Peony Medical Recent Developments
11.8 Guangzhou OCI Medical
11.8.1 Guangzhou OCI Medical Corporation Information
11.8.2 Guangzhou OCI Medical Business Overview
11.8.3 Guangzhou OCI Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.8.4 Guangzhou OCI Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Guangzhou OCI Medical Recent Developments
11.9 Koncen Biotech
11.9.1 Koncen Biotech Corporation Information
11.9.2 Koncen Biotech Business Overview
11.9.3 Koncen Biotech Blood Purification Therapy Product Models, Descriptions and Specifications
11.9.4 Koncen Biotech Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Koncen Biotech Recent Developments
11.10 Ningbo Tianyi Medical
11.10.1 Ningbo Tianyi Medical Corporation Information
11.10.2 Ningbo Tianyi Medical Business Overview
11.10.3 Ningbo Tianyi Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.10.4 Ningbo Tianyi Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Ningbo Tianyi Medical Recent Developments
11.11 Wellead Medical
11.11.1 Wellead Medical Corporation Information
11.11.2 Wellead Medical Business Overview
11.11.3 Wellead Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.11.4 Wellead Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Wellead Medical Recent Developments
11.12 Shinva
11.12.1 Shinva Corporation Information
11.12.2 Shinva Business Overview
11.12.3 Shinva Blood Purification Therapy Product Models, Descriptions and Specifications
11.12.4 Shinva Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Shinva Recent Developments
11.13 Chengdu Wesley
11.13.1 Chengdu Wesley Corporation Information
11.13.2 Chengdu Wesley Business Overview
11.13.3 Chengdu Wesley Blood Purification Therapy Product Models, Descriptions and Specifications
11.13.4 Chengdu Wesley Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Chengdu Wesley Recent Developments
11.14 Tuoren Medical
11.14.1 Tuoren Medical Corporation Information
11.14.2 Tuoren Medical Business Overview
11.14.3 Tuoren Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.14.4 Tuoren Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Tuoren Medical Recent Developments
11.15 Jiangxi Hongda
11.15.1 Jiangxi Hongda Corporation Information
11.15.2 Jiangxi Hongda Business Overview
11.15.3 Jiangxi Hongda Blood Purification Therapy Product Models, Descriptions and Specifications
11.15.4 Jiangxi Hongda Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Jiangxi Hongda Recent Developments
11.16 Guanhuai Medical
11.16.1 Guanhuai Medical Corporation Information
11.16.2 Guanhuai Medical Business Overview
11.16.3 Guanhuai Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.16.4 Guanhuai Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Guanhuai Medical Recent Developments
11.17 Guangzhou Jihua
11.17.1 Guangzhou Jihua Corporation Information
11.17.2 Guangzhou Jihua Business Overview
11.17.3 Guangzhou Jihua Blood Purification Therapy Product Models, Descriptions and Specifications
11.17.4 Guangzhou Jihua Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Guangzhou Jihua Recent Developments
11.18 Kangbei Medical
11.18.1 Kangbei Medical Corporation Information
11.18.2 Kangbei Medical Business Overview
11.18.3 Kangbei Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.18.4 Kangbei Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Kangbei Medical Recent Developments
11.19 Foshan Biosun Medical
11.19.1 Foshan Biosun Medical Corporation Information
11.19.2 Foshan Biosun Medical Business Overview
11.19.3 Foshan Biosun Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.19.4 Foshan Biosun Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Foshan Biosun Medical Recent Developments
11.20 Fresenius Medical Care
11.20.1 Fresenius Medical Care Corporation Information
11.20.2 Fresenius Medical Care Business Overview
11.20.3 Fresenius Medical Care Blood Purification Therapy Product Models, Descriptions and Specifications
11.20.4 Fresenius Medical Care Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Fresenius Medical Care Recent Developments
11.21 Nikkiso
11.21.1 Nikkiso Corporation Information
11.21.2 Nikkiso Business Overview
11.21.3 Nikkiso Blood Purification Therapy Product Models, Descriptions and Specifications
11.21.4 Nikkiso Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Nikkiso Recent Developments
11.22 B. Braun
11.22.1 B. Braun Corporation Information
11.22.2 B. Braun Business Overview
11.22.3 B. Braun Blood Purification Therapy Product Models, Descriptions and Specifications
11.22.4 B. Braun Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 B. Braun Recent Developments
11.23 Vantive
11.23.1 Vantive Corporation Information
11.23.2 Vantive Business Overview
11.23.3 Vantive Blood Purification Therapy Product Models, Descriptions and Specifications
11.23.4 Vantive Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Vantive Recent Developments
11.24 Asahi Kasei Medical
11.24.1 Asahi Kasei Medical Corporation Information
11.24.2 Asahi Kasei Medical Business Overview
11.24.3 Asahi Kasei Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.24.4 Asahi Kasei Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Asahi Kasei Medical Recent Developments
11.25 Nipro
11.25.1 Nipro Corporation Information
11.25.2 Nipro Business Overview
11.25.3 Nipro Blood Purification Therapy Product Models, Descriptions and Specifications
11.25.4 Nipro Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Nipro Recent Developments
11.26 Toray Medical
11.26.1 Toray Medical Corporation Information
11.26.2 Toray Medical Business Overview
11.26.3 Toray Medical Blood Purification Therapy Product Models, Descriptions and Specifications
11.26.4 Toray Medical Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Toray Medical Recent Developments
11.27 Kaneka Medix
11.27.1 Kaneka Medix Corporation Information
11.27.2 Kaneka Medix Business Overview
11.27.3 Kaneka Medix Blood Purification Therapy Product Models, Descriptions and Specifications
11.27.4 Kaneka Medix Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.27.5 Kaneka Medix Recent Developments
11.28 CytoSorbents
11.28.1 CytoSorbents Corporation Information
11.28.2 CytoSorbents Business Overview
11.28.3 CytoSorbents Blood Purification Therapy Product Models, Descriptions and Specifications
11.28.4 CytoSorbents Blood Purification Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
11.28.5 CytoSorbents Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Blood Purification Therapy Industry Chain
12.2 Blood Purification Therapy Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Blood Purification Therapy Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Blood Purification Therapy Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Blood Purification Therapy Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Blood Purification Therapy Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1. Global Blood Purification Therapy Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Blood Purification Therapy Market Size Growth Rate by Product Form, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Blood Purification Therapy Market Size Growth Rate by Care Setting, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Blood Purification Therapy Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Blood Purification Therapy Revenue by Region (US$ Million), 2021-2026
Table 7. Global Blood Purification Therapy Revenue by Region (US$ Million), 2027-2032
Table 8. Global Blood Purification Therapy Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Blood Purification Therapy Sales by Region (K Units), 2021-2026
Table 10. Global Blood Purification Therapy Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Blood Purification Therapy Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Blood Purification Therapy Sales Share by Manufacturers (2021-2026)
Table 14. Global Blood Purification Therapy Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Blood Purification Therapy Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Blood Purification Therapy Revenue, 2025
Table 18. Global Blood Purification Therapy Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Blood Purification Therapy Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Blood Purification Therapy Manufacturing Base and Headquarters
Table 21. Global Blood Purification Therapy Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Blood Purification Therapy Sales Volume by Type (K Units), 2021-2026
Table 25. Global Blood Purification Therapy Sales Volume by Type (K Units), 2027-2032
Table 26. Global Blood Purification Therapy Revenue by Type (US$ Million), 2021-2026
Table 27. Global Blood Purification Therapy Revenue by Type (US$ Million), 2027-2032
Table 28. Global Blood Purification Therapy Sales Volume by Product Form (K Units), 2021-2026
Table 29. Global Blood Purification Therapy Sales Volume by Product Form (K Units), 2027-2032
Table 30. Global Blood Purification Therapy Revenue by Product Form (US$ Million), 2021-2026
Table 31. Global Blood Purification Therapy Revenue by Product Form (US$ Million), 2027-2032
Table 32. Global Blood Purification Therapy Sales Volume by Care Setting (K Units), 2021-2026
Table 33. Global Blood Purification Therapy Sales Volume by Care Setting (K Units), 2027-2032
Table 34. Global Blood Purification Therapy Revenue by Care Setting (US$ Million), 2021-2026
Table 35. Global Blood Purification Therapy Revenue by Care Setting (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Blood Purification Therapy Sales by Application (K Units), 2021-2026
Table 38. Global Blood Purification Therapy Sales by Application (K Units), 2027-2032
Table 39. Blood Purification Therapy High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Blood Purification Therapy Revenue by Application (US$ Million), 2021-2026
Table 41. Global Blood Purification Therapy Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Blood Purification Therapy Growth Accelerators and Market Barriers
Table 45. North America Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Blood Purification Therapy Growth Accelerators and Market Barriers
Table 48. Europe Blood Purification Therapy Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Blood Purification Therapy Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Blood Purification Therapy Growth Accelerators and Market Barriers
Table 53. Southeast Asia Blood Purification Therapy Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Blood Purification Therapy Investment Opportunities and Key Challenges
Table 55. Central and South America Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Blood Purification Therapy Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Blood Purification Therapy Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Chongqing Shanwaishan Corporation Information
Table 59. Chongqing Shanwaishan Description and Major Businesses
Table 60. Chongqing Shanwaishan Product Models, Descriptions and Specifications
Table 61. Chongqing Shanwaishan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Chongqing Shanwaishan Sales Value Proportion by Product in 2025
Table 63. Chongqing Shanwaishan Sales Value Proportion by Application in 2025
Table 64. Chongqing Shanwaishan Sales Value Proportion by Geographic Area in 2025
Table 65. Chongqing Shanwaishan Blood Purification Therapy SWOT Analysis
Table 66. Chongqing Shanwaishan Recent Developments
Table 67. Weigao Corporation Information
Table 68. Weigao Description and Major Businesses
Table 69. Weigao Product Models, Descriptions and Specifications
Table 70. Weigao Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Weigao Sales Value Proportion by Product in 2025
Table 72. Weigao Sales Value Proportion by Application in 2025
Table 73. Weigao Sales Value Proportion by Geographic Area in 2025
Table 74. Weigao Blood Purification Therapy SWOT Analysis
Table 75. Weigao Recent Developments
Table 76. Sanxin Medtec Corporation Information
Table 77. Sanxin Medtec Description and Major Businesses
Table 78. Sanxin Medtec Product Models, Descriptions and Specifications
Table 79. Sanxin Medtec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Sanxin Medtec Sales Value Proportion by Product in 2025
Table 81. Sanxin Medtec Sales Value Proportion by Application in 2025
Table 82. Sanxin Medtec Sales Value Proportion by Geographic Area in 2025
Table 83. Sanxin Medtec Blood Purification Therapy SWOT Analysis
Table 84. Sanxin Medtec Recent Developments
Table 85. Biolight Corporation Information
Table 86. Biolight Description and Major Businesses
Table 87. Biolight Product Models, Descriptions and Specifications
Table 88. Biolight Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Biolight Sales Value Proportion by Product in 2025
Table 90. Biolight Sales Value Proportion by Application in 2025
Table 91. Biolight Sales Value Proportion by Geographic Area in 2025
Table 92. Biolight Blood Purification Therapy SWOT Analysis
Table 93. Biolight Recent Developments
Table 94. Bain Medical Corporation Information
Table 95. Bain Medical Description and Major Businesses
Table 96. Bain Medical Product Models, Descriptions and Specifications
Table 97. Bain Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Bain Medical Sales Value Proportion by Product in 2025
Table 99. Bain Medical Sales Value Proportion by Application in 2025
Table 100. Bain Medical Sales Value Proportion by Geographic Area in 2025
Table 101. Bain Medical Blood Purification Therapy SWOT Analysis
Table 102. Bain Medical Recent Developments
Table 103. Jafron Biomedical Corporation Information
Table 104. Jafron Biomedical Description and Major Businesses
Table 105. Jafron Biomedical Product Models, Descriptions and Specifications
Table 106. Jafron Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Jafron Biomedical Recent Developments
Table 108. Peony Medical Corporation Information
Table 109. Peony Medical Description and Major Businesses
Table 110. Peony Medical Product Models, Descriptions and Specifications
Table 111. Peony Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Peony Medical Recent Developments
Table 113. Guangzhou OCI Medical Corporation Information
Table 114. Guangzhou OCI Medical Description and Major Businesses
Table 115. Guangzhou OCI Medical Product Models, Descriptions and Specifications
Table 116. Guangzhou OCI Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Guangzhou OCI Medical Recent Developments
Table 118. Koncen Biotech Corporation Information
Table 119. Koncen Biotech Description and Major Businesses
Table 120. Koncen Biotech Product Models, Descriptions and Specifications
Table 121. Koncen Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Koncen Biotech Recent Developments
Table 123. Ningbo Tianyi Medical Corporation Information
Table 124. Ningbo Tianyi Medical Description and Major Businesses
Table 125. Ningbo Tianyi Medical Product Models, Descriptions and Specifications
Table 126. Ningbo Tianyi Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Ningbo Tianyi Medical Recent Developments
Table 128. Wellead Medical Corporation Information
Table 129. Wellead Medical Description and Major Businesses
Table 130. Wellead Medical Product Models, Descriptions and Specifications
Table 131. Wellead Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Wellead Medical Recent Developments
Table 133. Shinva Corporation Information
Table 134. Shinva Description and Major Businesses
Table 135. Shinva Product Models, Descriptions and Specifications
Table 136. Shinva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shinva Recent Developments
Table 138. Chengdu Wesley Corporation Information
Table 139. Chengdu Wesley Description and Major Businesses
Table 140. Chengdu Wesley Product Models, Descriptions and Specifications
Table 141. Chengdu Wesley Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Chengdu Wesley Recent Developments
Table 143. Tuoren Medical Corporation Information
Table 144. Tuoren Medical Description and Major Businesses
Table 145. Tuoren Medical Product Models, Descriptions and Specifications
Table 146. Tuoren Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Tuoren Medical Recent Developments
Table 148. Jiangxi Hongda Corporation Information
Table 149. Jiangxi Hongda Description and Major Businesses
Table 150. Jiangxi Hongda Product Models, Descriptions and Specifications
Table 151. Jiangxi Hongda Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Jiangxi Hongda Recent Developments
Table 153. Guanhuai Medical Corporation Information
Table 154. Guanhuai Medical Description and Major Businesses
Table 155. Guanhuai Medical Product Models, Descriptions and Specifications
Table 156. Guanhuai Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Guanhuai Medical Recent Developments
Table 158. Guangzhou Jihua Corporation Information
Table 159. Guangzhou Jihua Description and Major Businesses
Table 160. Guangzhou Jihua Product Models, Descriptions and Specifications
Table 161. Guangzhou Jihua Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Guangzhou Jihua Recent Developments
Table 163. Kangbei Medical Corporation Information
Table 164. Kangbei Medical Description and Major Businesses
Table 165. Kangbei Medical Product Models, Descriptions and Specifications
Table 166. Kangbei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Kangbei Medical Recent Developments
Table 168. Foshan Biosun Medical Corporation Information
Table 169. Foshan Biosun Medical Description and Major Businesses
Table 170. Foshan Biosun Medical Product Models, Descriptions and Specifications
Table 171. Foshan Biosun Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Foshan Biosun Medical Recent Developments
Table 173. Fresenius Medical Care Corporation Information
Table 174. Fresenius Medical Care Description and Major Businesses
Table 175. Fresenius Medical Care Product Models, Descriptions and Specifications
Table 176. Fresenius Medical Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Fresenius Medical Care Recent Developments
Table 178. Nikkiso Corporation Information
Table 179. Nikkiso Description and Major Businesses
Table 180. Nikkiso Product Models, Descriptions and Specifications
Table 181. Nikkiso Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Nikkiso Recent Developments
Table 183. B. Braun Corporation Information
Table 184. B. Braun Description and Major Businesses
Table 185. B. Braun Product Models, Descriptions and Specifications
Table 186. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. B. Braun Recent Developments
Table 188. Vantive Corporation Information
Table 189. Vantive Description and Major Businesses
Table 190. Vantive Product Models, Descriptions and Specifications
Table 191. Vantive Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Vantive Recent Developments
Table 193. Asahi Kasei Medical Corporation Information
Table 194. Asahi Kasei Medical Description and Major Businesses
Table 195. Asahi Kasei Medical Product Models, Descriptions and Specifications
Table 196. Asahi Kasei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Asahi Kasei Medical Recent Developments
Table 198. Nipro Corporation Information
Table 199. Nipro Description and Major Businesses
Table 200. Nipro Product Models, Descriptions and Specifications
Table 201. Nipro Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Nipro Recent Developments
Table 203. Toray Medical Corporation Information
Table 204. Toray Medical Description and Major Businesses
Table 205. Toray Medical Product Models, Descriptions and Specifications
Table 206. Toray Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Toray Medical Recent Developments
Table 208. Kaneka Medix Corporation Information
Table 209. Kaneka Medix Description and Major Businesses
Table 210. Kaneka Medix Product Models, Descriptions and Specifications
Table 211. Kaneka Medix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 212. Kaneka Medix Recent Developments
Table 213. CytoSorbents Corporation Information
Table 214. CytoSorbents Description and Major Businesses
Table 215. CytoSorbents Product Models, Descriptions and Specifications
Table 216. CytoSorbents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 217. CytoSorbents Recent Developments
Table 218. Key Raw Materials Distribution
Table 219. Raw Materials Key Suppliers
Table 220. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 221. Milestones in Production Technology Evolution
Table 222. Distributors List
Table 223. Market Trends and Market Evolution
Table 224. Market Drivers and Opportunities
Table 225. Market Challenges, Risks, and Restraints
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources

List of Figures
Figure 1. Blood Purification Therapy Product Picture
Figure 2. Global Blood Purification Therapy Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Hemodialysis Product Picture
Figure 4. Hemoperfusion Product Picture
Figure 5. Hemofiltration Product Picture
Figure 6. Continuous Renal Replacement Therapy Product Picture
Figure 7. Plasma Exchange And Plasma Adsorption Product Picture
Figure 8. Other Product Picture
Figure 9. Global Blood Purification Therapy Market Size Growth Rate by Product Form, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Blood Purification Equipment Product Picture
Figure 11. Blood Purification Consumables Product Picture
Figure 12. Global Blood Purification Therapy Market Size Growth Rate by Care Setting, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Hospitals Product Picture
Figure 14. Blood Purification Centers Product Picture
Figure 15. Home Care Product Picture
Figure 16. Other Product Picture
Figure 17. Global Blood Purification Therapy Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 18. End-Stage Kidney Disease Requiring Long-Term Renal Replacement Therapy
Figure 19. Acute Kidney Injury And Critical Care Blood Purification
Figure 20. Liver Failure And Artificial Liver Support
Figure 21. Poisoning Blood Purification
Figure 22. Immune-Mediated Disease Blood Purification
Figure 23. Metabolic Diseases and Special Component Removal
Figure 24. Other
Figure 25. Blood Purification Therapy Report Years Considered
Figure 26. Global Blood Purification Therapy Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 28. Global Blood Purification Therapy Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 29. Global Blood Purification Therapy Revenue-Based Market Share by Region (2021-2032)
Figure 30. Global Blood Purification Therapy Sales (K Units), 2021-2032
Figure 31. Global Blood Purification Therapy Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 32. Global Blood Purification Therapy Sales Market Share by Region (2021-2032)
Figure 33. Top 5 and Top 10 Manufacturers Blood Purification Therapy Sales Volume Market Share in 2025
Figure 34. Global Blood Purification Therapy Revenue-Based Market Share Ranking (2025)
Figure 35. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 36. Hemodialysis Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Hemoperfusion Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Hemofiltration Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Continuous Renal Replacement Therapy Revenue-Based Market Share by Manufacturer in 2025
Figure 40. Plasma Exchange And Plasma Adsorption Revenue-Based Market Share by Manufacturer in 2025
Figure 41. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 42. Global Blood Purification Therapy Sales Volume-Based Market Share by Type (2021-2032)
Figure 43. Global Blood Purification Therapy Revenue-Based Market Share by Type (2021-2032)
Figure 44. Global Blood Purification Therapy ASP by Type (US$/Unit), 2021-2032
Figure 45. Global Blood Purification Therapy Sales Volume-Based Market Share by Product Form (2021-2032)
Figure 46. Global Blood Purification Therapy Revenue-Based Market Share by Product Form (2021-2032)
Figure 47. Global Blood Purification Therapy ASP by Product Form (US$/Unit), 2021-2032
Figure 48. Global Blood Purification Therapy Sales Volume-Based Market Share by Care Setting (2021-2032)
Figure 49. Global Blood Purification Therapy Revenue-Based Market Share by Care Setting (2021-2032)
Figure 50. Global Blood Purification Therapy ASP by Care Setting (US$/Unit), 2021-2032
Figure 51. Global Blood Purification Therapy Sales Market Share by Application (2021-2032)
Figure 52. Global Blood Purification Therapy Revenue-Based Market Share by Application (2021-2032)
Figure 53. Global Blood Purification Therapy ASP by Application (US$/Unit), 2021-2032
Figure 54. North America Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 55. North America Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 56. North America Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 57. North America Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 58. North America Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. US Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 60. Canada Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 61. Mexico Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 62. Europe Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 63. Europe Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 64. Europe Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 65. Europe Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 66. Europe Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Germany Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 68. France Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 69. U.K. Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 70. Italy Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 71. Russia Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 72. Asia-Pacific Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 73. Asia-Pacific Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 74. Asia-Pacific Top 8 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 75. Asia-Pacific Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 76. Asia-Pacific Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Indonesia Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 78. Japan Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 79. South Korea Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 80. China Taiwan Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 81. India Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 82. Central and South America Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 83. Central and South America Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 84. Central and South America Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 85. Central and South America Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 86. Central and South America Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 87. Brazil Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 88. Argentina Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 89. Middle East, and Africa Blood Purification Therapy Sales YoY (K Units), 2021-2032
Figure 90. Middle East and Africa Blood Purification Therapy Revenue YoY (US$ Million), 2021-2032
Figure 91. Middle East and Africa Top 5 Manufacturers Blood Purification Therapy Sales Revenue (US$ Million) in 2025
Figure 92. Middle East and Africa Blood Purification Therapy Sales Volume (K Units) by Application (2021-2032)
Figure 93. Middle East and Africa Blood Purification Therapy Sales Revenue (US$ Million) by Application (2021-2032)
Figure 94. GCC Countries Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 95. Turkey Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 96. Egypt Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 97. South Africa Blood Purification Therapy Revenue (US$ Million), 2021-2032
Figure 98. Blood Purification Therapy Industry Chain Mapping
Figure 99. Regional Blood Purification Therapy Manufacturing Base Distribution (%)
Figure 100. Global Blood Purification Therapy Production Market Share by Region (2021-2032)
Figure 101. Blood Purification Therapy Production Process
Figure 102. Regional Blood Purification Therapy Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

QYResearch社の 医療機器・消耗品分野 での最新刊レポート

本レポートと同じKEY WORD（blood）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

当社ご利用のメリット
  1. ① お探しの情報に合わせてレポートをご紹介
  2. ② レポートで不足している情報はカスタマイズで対応可能
  3. ③ 特許情報、海外の法規制の取り組みなどディープな調査も対応可能
  4. ④ 円貨で請求書払い＆万全のアフターフォロー

 

2026/10/23　10:26

157.51 円

177.10 円

213.82 円

ページTOPに戻る

株式会社 データリソース　Data Resource, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430


A member of CORSS Business Producers Inc.
データリソースは2025年5月より
CROSS Business Producers株式会社 の100%子会社になりました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCE, Inc. ALL RIGHTS RESERVED.